(Q39681268)

13 September 2017

title

MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells (English)

1 reference

13 September 2017

1 reference

Zhimin Li

1

1 reference

13 September 2017

Sha Hu

2

1 reference

13 September 2017

Jing Wang

3

1 reference

13 September 2017

Jing Cai

4

1 reference

13 September 2017

Lan Xiao

5

1 reference

13 September 2017

Lili Yu

6

1 reference

13 September 2017

Zehua Wang

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

10 July 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

119

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

125-130

1 reference

13 September 2017

cites work

Carcinoma of the Ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

The Role of ABC Transporters in Clinical Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

MicroRNAs and cancer: profile, profile, profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

OncomiRs: the discovery and progress of microRNAs in cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

MicroRNAs as oncogenes and tumor suppressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Role of microRNA in anticancer drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Role of microRNAs in drug-resistant ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

miR-21-mediated tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

A brain-specific microRNA regulates dendritic spine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Inhibition of microRNA with antisense oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.06.004

10.1016/J.YGYNO.2010.06.004

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference